Department of Surgery, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Arch Iran Med. 2012 Dec;15(12):772-6.
Liver transplantation (LTx) is the treatment of choice for patients with end-stage liver disease (ESLD). Improvement in outcomes (allograft and patient survival) has led to widespread use of LTx worldwide. However, new problems that include severe organ shortage, recurrence of primary disease, opportunistic infections, and development of de novo malignancies are the major problems affecting further implementation of LTx.
肝移植(LTx)是治疗终末期肝病(ESLD)患者的首选方法。结局的改善(移植物和患者存活率)导致 LTx 在全球范围内广泛应用。然而,包括严重的器官短缺、原发病复发、机会性感染和新发生的恶性肿瘤在内的新问题是影响进一步实施 LTx 的主要问题。